Latest Breaking News & Top Headlines

Cancer patients who have recently been treated are 75% more likely to die from Covid

0

Cancer patients who have recently received treatment are at increased risk of serious illness and death from COVID-19, a new study suggests.

Researchers at the University of Texas Cancer Center, one of the nation’s largest cancer centers in Houston, collected data on various Covid outcomes for cancer patients, depending on the type of treatment they received.

They found that cancer patients who received treatment in the past three months were 74 percent more likely to die from the virus and 69 percent more likely to be admitted to the intensive care unit (ICU) than those without cancer.

Patients treated with chemotherapy or chemoimmunotherapy were most at risk, although researchers don’t explain why.

Surprisingly, people with cancer who had not been treated recently were not at increased risk of serious consequences from COVID-19.

The team believes the findings mean that cancer patients who contract COVID-19 cannot all be treated the same, as they may have very different needs depending on the recent treatment of their tumors.

Cancer patients who received treatment in the three months before contracting COVID-19 had a much higher risk of the virus, with 74% more likely to die and 69% more likely to be admitted to an ICU, although patients without recent treatment same death rates and ICU visits as non-cancer patients

Researchers aren't sure what to make of these results, though they feel cancer patients shouldn't all be lumped together when being treated for the virus (file image)

Researchers aren’t sure what to make of these results, though they feel cancer patients shouldn’t all be lumped together when being treated for the virus (file image)

“Patients without recent cancer treatment had a similar risk of death and ICU stay and a lower risk of mechanical ventilation and hospitalization compared to patients without cancer,” the team wrote.

“This finding suggests that cancer patients are a heterogeneous group, and risk stratification according to recent treatment and the treatment administered has important implications for patients, clinicians and the health care system.”

Researchers, who published their findings Thursday in JAMA Oncology, collected data from 507,307 COVID-19 patients in the U.S.

Just under three percent of them, or 14,287, were cancer patients, and 30 percent had recently received treatment for their condition.

The patients were divided into three groups: the control group with non-cancer patients, cancer patients who received treatment recently and patients who received no treatment.

“We found that cancer patients tended to be older and had more comorbidities than the general population,” the authors wrote.

‘Older age, male gender, comorbidities, race and ethnicity, and severe obesity were all associated with adverse outcomes in this study.’

While cancer patients generally had worse health outcomes than the average person, the team found that these negative outcomes were concentrated in the patients who had received some type of treatment.

For example, cancer patients who had recently received treatment were 74 percent more likely to die from Covid, although the death rate among those who had not recently received treatment was found to be only seven percent lower than average.

People who had recently received cancer treatment were also 69 percent more likely to be admitted to an intensive care unit for Covid treatment, while those who had not received treatment had about the same percentage as the control group.

Researchers also found that people with certain types of tumors or who had received certain treatments were most at risk for Covid.

“Patients with metastatic solid tumors, and especially those with hematologic malignant neoplasms, had worse outcomes,” they wrote.

“Recent systemic therapy, particularly chemotherapy and chemoimmunotherapy, have been associated with adverse outcomes.”

Having cancer but not receiving treatment seemed to have little impact on whether a person would need a ventilator or hospitalization, and those without recent cancer treatment had even lower rates than the general population.

The results of this study add to an inconsistent set of data that experts worldwide have on how cancer and cancer treatment affect a person’s Covid outcome.

“Data on the implications of cancer therapies for outcomes in patients with COVID-19 have been inconsistent,” they wrote.

“Several studies have shown a link between recent treatment and adverse outcomes, while others have not.”

.

Leave A Reply

Your email address will not be published.